Compare IDEXX Laboratories, Inc. (IDXX) vs Ulta Beauty Inc (ULTA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
IDEXX Laboratories, Inc. vs Ulta Beauty Inc — how do they compare? IDEXX Laboratories, Inc. trades at $518 (market cap $40.43B), while Ulta Beauty Inc trades at $570.37 (market cap $24.12B). The key difference: IDEXX Laboratories, Inc. is the larger of the two by market cap, and Ulta Beauty Inc is trading nearer its 52-week high, IDEXX Laboratories, Inc. nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold IDEXX Laboratories, Inc. for 46 Days and Ulta Beauty Inc for 92 Days on average.
| IDXX | ULTA | |
|---|---|---|
Market Cap | $40.43B | $24.12B |
Volume | 692,164 | 457,598 |
Sector | Health | Consumer Cyclical |
52-Week High | $766.68 | $706.82 |
52-Week Low | $504.70 | $450.75 |
Typical Hold Time | 46 Days | 92 Days |
Enterprise Value | $41.32B | $26.43B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IDEXX Laboratories (IDXX) trades at $513.14, up 1.28% with strong fundamentals including 25.03% net income margin and 74.21% ROE. The stock shows bearish technical signals but maintains consistent earnings beats and analyst consensus of $665 price target. Recent acquisition of CoVetAI expands AI capabilities in veterinary workflow intelligence, supporting long-term growth framework.
Outlook remains positive with revenue growth accelerating to $4.3B in 2025 and projected $4.6B in 2026. Key risks include foreign exchange headwinds and weaker U.S. veterinary visits. The 56.5% buy rating from analysts suggests continued confidence in the company's diagnostic innovation pipeline and recurring revenue economics.
ULTA trades at $564.21, up 3.43% today, with a bullish technical outlook and strong institutional support. Recent Q2 2026 earnings beat expectations, and the company raised its 2026 guidance, driven by e-commerce momentum. Valuation metrics show a P/E of 20.55 and P/S of 1.92, while profitability remains robust with a 9.34% net income margin and 46.12% ROE.
The stock offers growth potential with a consensus price target of $624.93, but faces risks from margin pressure and flat store traffic. Execution on raised guidance and expansion into wellness categories are key catalysts, though consumer spending volatility and promotional intensity could limit upside.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →About Ulta Beauty Inc
With more than 1,300 stores and a partnership with Target, Ulta Beauty is the largest specialized beauty retailer in the U.S. The firm offers makeup (43% of 2021 sales), fragrances, skin care, and hair care products (20% of 2021 sales), and bath and body items. Ulta offers private-label products and merchandise from more than 500 vendors. It also offers salon services, including hair, makeup, skin, and brow services, in all stores. Most Ulta stores are approximately 10,000 square feet and are in suburban strip centers. Ulta was founded in 1990 and is based in Bolingbrook, Illinois.
Read more on ULTA →
